Detecting Ultralow-Frequency Mutations by Duplex Sequencing - TwinStrand Biosciences

Skip to content

NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

Technology
Products
- AML Assay
- Mutagenesis Assay
Services
- Nitrosamine Testing
- Mutagenesis Testing
Resources
- Publications
- Posters
- Safety
- Patents
Company
- Our Team
- Events
- News
- Investors

Menu

Technology
Products
- AML Assay
- Mutagenesis Assay
Services
- Nitrosamine Testing
- Mutagenesis Testing
Resources
- Publications
- Posters
- Safety
- Patents
Company
- Our Team
- Events
- News
- Investors

Detecting Ultralow-Frequency Mutations by Duplex Sequencing

For Research Use Only. Not for use in diagnostic procedures.

©2024 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices

Stay up to date

Danielle LeBlanc is a Biologist at Health Canada under the supervision of Dr. Francesco Marchetti. Danielle completed her undergraduate and Masters work at Carleton University in Ottawa. Danielle is currently focusing on the implementation of Duplex Sequencing for in vivo mutagenesis assessment at Health Canada.

In her spare time, she loves to cross-country ski, bake cupcakes and craft cocktails.

Dr. Francesco Marchetti is a Senior Research Scientist at Health Canada and Adjunct Research Professor at Carleton University. He chairs the Germ Cell workgroup of the Health and Environmental Science Institute’s Genetic Toxicology Technical Committee and is a member of the Organisation for the Economic Co-Operation and Development Expert Group on Genotoxicity Testing. Dr. Marchetti has authored over 125 peer-reviewed publications.

He was Editor-In-Chief of Environmental and Molecular Mutagenesis (EMM) during 2012-2016 and serves on the editorial boards of EMM and Mutagenesis. Dr. Marchetti is the current President of the Environmental Mutagenesis and Genomic Society.